MEI Pharma, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, California

Insiders trading volume in the past year

MEI Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anson Funds Management LP 10%+ Owner $7.65M +$1.27M +19.9% Oct 20, 2023
Funicular Funds, LP 10%+ Owner $4.28M +$845K +24.6% Oct 20, 2023
Charles V. Baltic III Director $778K Sep 29, 2023
Steven D. Wood Director $229K May 17, 2024
James P. Flynn Director $25K May 16, 2024
Cheryl Cohen Director Jul 5, 2022
Thomas C. Reynolds Director Sep 29, 2023
Frederick Driscoll Director Sep 29, 2023
Richard G. Ghalie Chief Medical Officer Sep 29, 2023
Tamar Howson Director Sep 29, 2023
Christine Anna White Director Jul 5, 2022
Justin J. File CFO and Corporate Secretary Jun 12, 2023
Sujay Kango Director Sep 29, 2023
Daniel P. Gold Phd Director Sep 29, 2023
Taheer Datoo Director Oct 31, 2023
Nicholas Glover Director Sep 20, 2023
David M. Urso President and CEO, Director Jun 2, 2023
Brian G. Drazba Chief Financial Officer Jul 5, 2022
Kevan Clemens Director Jul 1, 2021

Recent Insider Transactions by Companies or Individuals for MEI Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.